HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.

The Los Angeles County Department of Public Health received notice from the U.S. Centers for Disease Control and Prevention ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

The United States Food and Drug Administration has approved lenacapavir, an injectable drug that offers long-lasting ...

Congressional leaders celebrated the restored $20 million in previously frozen HIV prevention funds and surveillance programs ...

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...

"We don't want to shut these doors, we want to make sure they stay open and we can help as many people as we can".